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Gastrointestinal follicular lymphoma: a retrospective analysis of 16 cases
YY Hwang, CS Chim, WY Au, E Tse, AYH Leung, YL Kwong
Division of Haematology and Haematological Oncology, Department of Medicine, The University of Hong Kong, Queen Mary 
Hospital, Hong Kong
Objective: To investigate the clinical behaviour, treatment response, and prognosis of primary gastrointestinal follicular 
lymphoma.
Method: Clinical records of all follicular lymphoma diagnosed at Queen Mary Hospital from 1988 to 2008 were 
reviewed. Cases with gastrointestinal tract as the only or predominant site of involvement at presentation were 
considered to be primary gastrointestinal follicular lymphoma. Patient demographics, disease staging, treatment and 
outcome were analysed.
Results: There were 155 cases of follicular lymphoma diagnosed from 1988 to 2008, of which 123 cases were 
nodal and 32 cases were extranodal. Sixteen cases of primary gastrointestinal follicular lymphoma were identified, 
constituting 10.3% (16/155) of all follicular lymphomas, and 50% (16/32) of extranodal follicular lymphomas. 
There was a slight male predominance (male:female=1.67:1), presenting at a median age of 60.5 (28-85) years. The 
majority of patients (12/16, 75%) presented with advanced Ann-Arbor stage (stage III or IV). The Follicular Lymphoma 
International Prognostic Index was evaluated in 13 cases, and seven (53.8%) patients were classified as high-risk. 
Common primary sites were ileum (n=6), colon (n=5), and duodenum (n=3). The complete remission rate after first-
line chemotherapy was 43.7% and the median duration of progression-free survival was 19 (1-156) months. The 
median overall survival was 54.5 (8-264) months. At a median follow-up of 93 (16-267) months, five patients had 
died—four from unrelated diseases and one from refractory lymphoma. The median progression-free survival of nodal 
follicular lymphoma in this cohort was 23.5 (1-228) months and median overall survival was 76 (5-790) months.
Conclusions: The gastrointestinal tract was the most common site of extranodal follicular lymphoma. In this cohort, 
primary gastrointestinal follicular lymphoma had a worse clinical outcome as compared with nodal follicular 
lymphoma.
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microRNA-21 promotes survival but not functional maturation of human embryonic stem  
cell–derived cardiomyocytes (hESC-CMs)
CW Kong1, E Poon2, HM Yeung1, SN Rushing3, GP Chen4, RA Li1,3,4
1Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
2LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
3Mount Sinai School of Medicine, NY, United States
4Department of Physiology, The University of Hong Kong, Hong Kong
Purpose: microRNAs (miRNAs) are naturally occurring small non-encoding RNAs (22 nt) which negatively modulate 
gene expression via mRNA degradation and translational repression. Studies suggested that miRNAs are important 
in both normal cardiogenesis and pathogenesis of the failing heart. miRNA-21 is among those that are differentially 
expressed, according to our miRNAs profiling, and we hypothesised that its expression level may play a part in 
functional maturation of human embryonic stem cell–derived cardiomyocytes (hESC-CMs).
Methods: miRNA profiling was performed to identify differential expression of miRNAs in human embryonic stem cells 
(hESCs), hESC-derived, fetal (hF) and adult (hA) ventricular cardiomyocytes (VCMs). Overexpression and knockdown 
of miRNA-21 were achieved by lentivector (LV)–based system. To functionally characterise maturity, whole-cell patch-
clamp probing for the action potential (AP) profile, and cytosolic Ca2+ transients measurement were performed in 
control versus miRNA-21 overexpressed/knockdown hESC-CMs. Contractile protein and sarcoplasmic reticulum (SR) 
Ca2+ handling protein expression were quantified with qPCR.
Results: miRNA-21 was highly expressed in hESC and hESC-VCMs; repressed in hF-VCMs and hA-VCMs. We 
hypothesised its expression level might be associated with functional maturity. However, we did not find any 
significant functional changes of hESC-CMs by manipulating its expression. The expression of contractile protein and 
SR Ca2+ handling protein was not affected, consistent with the functional data. Previous studies suggested pro-survival 
effects of miRNA-21 overexpression during compensatory cardiac hypertrophy. We performed TUNEL assay and found 
that overexpressing miRNA-21 in hESC-CMs significantly protected the cells against apoptosis induced by hydrogen 
peroxide challenge.
Conclusions: Differential expression of miRNA-21 in hESCs, hESC-, hF- and hA-VCMs is apparently unrelated to global 
functional maturity of hESC-CMs. High level of miRNA-21 expression during embryonic stage might confer survival 
advantages to developing myocytes.
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